1. Welcome to the All Things Male Forum. Please sign up and join the conversation. It's free!

Single-centre Experience Of Testosterone Therapy For Boys With Hypogonadism.

Discussion in 'Scientific Studies' started by pubmed: testosterone, Jan 29, 2019.

  1. [​IMG]

    Single-Centre Experience of Testosterone Therapy for Boys with Hypogonadism.

    Horm Res Paediatr. 2018;90(2):123-127

    Authors: Lucas-Herald AK, Mason E, Beaumont P, Mason A, Shaikh MG, Wong SC, Ahmed SF

    Abstract
    BACKGROUND: Hypogonadism in boys is one of the commonest conditions encountered in paediatric endocrinology.
    AIMS: To study variations in management in a contemporary group of boys at a single specialist centre.
    METHODS: Retrospective review of case records of all boys treated with testosterone at a tertiary endocrine service from 2012 to 2017.
    RESULTS: Of the 358 boys reviewed for hypogonadism, 46 (13%) were initiated on testosterone therapy at a median age (range) of 14.2 years (12.1, 17.7). Indications for therapy included a functional delay of puberty that was constitutional in 17 (37%) or related to chronic disease in 10 (22%) or organic hypogonadism due to primary gonadal failure in 7 (15%), multiple pituitary hormone deficiency in 6 (13%), and isolated hypogonadotropic hypogonadism in 6 (13%). Of the 46 boys, 40 (89%) were started on intramuscular testosterone, 4 (9%) on oral testosterone, and 1 (2%) on transdermal gel. Of the 19 boys (40%) with organic hypogonadism re-quiring long-term therapy, 12 (63%) had assessment of liver function, 6 (32%) had a haematocrit, and 2 (11%) had a DXA scan in the year of commencing treatment.
    CONCLUSIONS: Testosterone therapy is administered in about 13% of boys reviewed for hypogonadism and its monitoring requires standardisation.

    PMID: 30021202 [PubMed - indexed for MEDLINE]

    Continue reading...
     

Share This Page

  1. This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.